Veröffentlichungen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Beule, Dieter Dr. (1) Blankenstein, Thomas Prof. Dr. (2) Blüthgen, Nils (1) Janz, Martin Dr. (5) Kammertöns, Thomas Dr. (1) Leisegang, Matthias Dr. (5) Lusatis, Simone (1) Mathas, Stephan Dr. (7) Selbach, Matthias Prof. Dr. (5) Uckert, Wolfgang Prof. Dr. (11) (-) Daniel, Peter Prof. Dr. (1) (-) Wollert-Wulf, Brigitte (2) (-) Biologie maligner Lymphome (3) Genetik und Genomik von Herz- Kreislauferkrankungen (1) (-) Molekulare Zellbiologie und Gentherapie (4) Signaltransduktion in Tumorzellen (1) Translationale Onkologie solider Tumore (1) 2001 (1) 2002 (2) 2003 (1) (-) 2006 (4) 2008 (2) (-) 2010 (2) 2013 (2) 2014 (3) 2015 (2) 2016 (1) 2017 (2) 2018 (1) 6 Ergebnisse: Active Filter: Daniel, Peter Prof. Dr.Wollert-Wulf, BrigitteBiologie maligner LymphomeMolekulare Zellbiologie und Gentherapie20062010 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Mai 2010 in Nat Med Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy G.M. Bendle C. Linnemann A.I. Hooijkaas L. Bies M.A. de Witte A. Jorritsma A.D.M. Kaiser N. Pouw R. Debets E. Kieback W. Uckert J.Y. Song J.B.A.G. Haanen T.N.M. Schumacher 01. Mai 2010 in Expert Opin Biol Ther Enhanced T cell receptor gene therapy for cancer E. Kieback W. Uckert 01. April 2006 in Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 15. März 2006 in Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 05. Februar 2006 in Virology Factors influencing subcellular localization of the human papillomavirus L2 minor structural protein E. Kieback M. Mueller 01. Februar 2006 in Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
01. Mai 2010 in Nat Med Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy G.M. Bendle C. Linnemann A.I. Hooijkaas L. Bies M.A. de Witte A. Jorritsma A.D.M. Kaiser N. Pouw R. Debets E. Kieback W. Uckert J.Y. Song J.B.A.G. Haanen T.N.M. Schumacher
01. Mai 2010 in Expert Opin Biol Ther Enhanced T cell receptor gene therapy for cancer E. Kieback W. Uckert
01. April 2006 in Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
15. März 2006 in Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
05. Februar 2006 in Virology Factors influencing subcellular localization of the human papillomavirus L2 minor structural protein E. Kieback M. Mueller
01. Februar 2006 in Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
